Aurealis Pharma

Castle Creek Biosciences

This company develops cell and gene therapies for patients suffering from rare genetic skin and connective tissue diseases.

Aegle Therapeutics

This company develops extracellular vesicle therapies derived from stem cells to treat patients with rare dermatological disorders and severe burns.

Sarcura

This company develops automated platforms for large-scale manufacturing of personalised cell therapies for the biopharmaceutical industry.

Anjarium BioSciences

This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.

VascVersa Ltd

This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Onya

This biotechnology company develops advanced therapies and medical dressings to treat chronic and acute wounds for patients with delayed healing.

GeniPhys

This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.